ENTECAVIR
NDC 50771-013, entecavir, tablet, film coated, from Yaopharma Co., Ltd..
- Product NDC
- 50771-013
- Status
- Listed
- Labeler
- Yaopharma Co., Ltd.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212201
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50771-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENTECAVIR.5 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50771-013-01 | 50771001301 | 30 TABLET, FILM COATED in 1 BOTTLE (50771-013-01) |
| 50771-013-02 | 50771001302 | 90 TABLET, FILM COATED in 1 BOTTLE (50771-013-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/73dea2a4-a596-477f-b66d-5a80dd019837
Use it
Look up 50771-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50771-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50771-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.